President & CEO, London Health Sciences Foundation
Topic: A message of welcome.
The below announcement is a presentation honouring a second transformational gift of $3M from Archie and Irene Verspeeten to the Archie and Irene Verspeeten Clinical Genome Centre.
In this virtual announcement, you will hear from world-leading cancer researchers and clinicians about how the Archie and Irene Verspeeten Clinical Genome Centre is revolutionizing treatment options for patients with diseases linked to genetics.
No two people are the same and genetic differences can mean even if a treatment works for one patient, it may not work for another.
The Archie and Irene Verspeeten Clinical Genome Centre aims to use genomic profiling to help create personalized treatment that will improve outcomes for patients with diseases linked to genetics such as cancer, epilepsy, neuromuscular disorders and developmental disabilities.
It is the first of its kind in Canada.